| __timestamp | Intra-Cellular Therapies, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 15411924 |
| Thursday, January 1, 2015 | 87718074 | 22593274 |
| Friday, January 1, 2016 | 93831530 | 33173050 |
| Sunday, January 1, 2017 | 79419009 | 62224159 |
| Monday, January 1, 2018 | 132166913 | 95607434 |
| Tuesday, January 1, 2019 | 89124838 | 221269028 |
| Wednesday, January 1, 2020 | 65782137 | 400745069 |
| Friday, January 1, 2021 | 88845513 | 580520000 |
| Saturday, January 1, 2022 | 134715000 | 663366000 |
| Sunday, January 1, 2023 | 180142000 | 755113687 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, argenx SE and Intra-Cellular Therapies, Inc. have demonstrated significant growth in their R&D investments.
From 2014 to 2023, argenx SE's R&D expenses surged by nearly 4,800%, reflecting its aggressive pursuit of groundbreaking therapies. By 2023, the company allocated approximately 75% more to R&D compared to Intra-Cellular Therapies, Inc., underscoring its strategic focus on innovation.
Intra-Cellular Therapies, Inc. also increased its R&D spending, with a notable 750% rise over the same period. This steady growth highlights the company's dedication to advancing its pipeline and maintaining a competitive edge.
Both companies exemplify the dynamic nature of the biotech industry, where R&D investment is pivotal for future success.
Who Prioritizes Innovation? R&D Spending Compared for Novartis AG and Intra-Cellular Therapies, Inc.
R&D Insights: How argenx SE and United Therapeutics Corporation Allocate Funds
Research and Development: Comparing Key Metrics for argenx SE and Insmed Incorporated
Research and Development Investment: argenx SE vs Blueprint Medicines Corporation
Research and Development Expenses Breakdown: argenx SE vs Grifols, S.A.
Research and Development Expenses Breakdown: BeiGene, Ltd. vs Intra-Cellular Therapies, Inc.
R&D Insights: How United Therapeutics Corporation and Intra-Cellular Therapies, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ascendis Pharma A/S
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Rhythm Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Xencor, Inc.